Kenota Health is transforming the allergy testing experience by providing rapid, lab-quality IgE testing directly in allergists' offices. Their proprietary system allows for accurate and less invasive testing, enabling allergists to diagnose allergies in a single visit without the need for lab referrals. With FDA 510(k) clearance and CLIA waiver approval, Kenota's technology is designed to improve patient outcomes and streamline the testing process. The company has established a scalable manufacturing facility and has raised $11 million in funding, positioning itself as a leader in the allergy diagnostics market.
Something looks off?